Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Date of authorisation: 22/07/2014, Revision: 21, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 17 March 2026 - 15:52

Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Date of authorisation: 22/07/2014, Revision: 21, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/gazyvaro

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters